The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Reading Rheum

Reading Rheum

April 1, 2007 • By Mary Corr, MD; Michael M. Ward, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Cadherin-11 May Be a Therapeutic Target in RA

By Mary Corr, MD

You Might Also Like
  • Reading Rheum
  • Reading Rheum
  • Reading RHEUM
Explore This Issue
April 2007

Lee DM, Kiener HP, Agarwal SK, et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science. 2007;315(5814):1006-1010.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Abstract

The normal synovium forms a membrane at the edges of joints and provides lubrication and nutrients for cartilage. In RA, the synovium is the site of inflammation, and it participates in an organized tissue response that damages cartilage and bone. We identified cadherin-11 as essential for development of the synovium. Cadherin-11–deficient mice have a hypoplastic synovial lining, display a disorganized synovial reaction to inflammation, and are resistant to inflammatory arthritis. Cadherin-11 therapeutics prevent and reduce arthritis in mouse models. Thus, synovial cadherin-11 determines the behavior of synovial cells in their proinflammatory and destructive tissue response in inflammatory arthritis.

Commentary

RA is a debilitating disease marked by bone and cartilage destruction. In the rheumatoid synovium, the fibroblast cells aggressively proliferate and invade the other joint structures. Indeed, these fibroblast-like synoviocytes develop genetic and phenotypic features similar to malignant cells, including expression of proto-oncogenes and loss of contact growth inhibition. Although these cells in the pannus locally invade, they never metastasize. Most of the current therapies for RA are directed toward other components of the immune system. There has been limited investigation into therapies that are directed against the aggressive behavior of the synovial fibroblasts. By targeting cadherin-11, an essential adhesion molecule for synovial development and mature architecture, Lee and colleagues are paving the way for another approach in our therapeutic armamentarium.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Figure 1. Synovial fibroblasts express functional cadherin-11. A and B: Normal synovium stained with either control (A) or anti-cadherin–11 (B) antisera. (Magnification, 650.) C and D: Arthritic K/BxN synovium. Synovial pannus invading cartilage stained with either control (C) or anti-cadherin–11 (D) antisera is shown. There is intense cellular reactivity at the bone/pannus interface. (Magnification, 400x.) Key: P, pannus; C, cartilage; B, bone.
Source: Science. 2007;315(5814):1007.

In a normal diarthrodial joint, the synovial lining is composed of synoviocytes that form an intact layer through cell-to-cell contacts with intervening matrix spaces. Cadherins are a family of adhesion molecules that bind to other cadherin molecules on neighboring cells. Cadherin-11 has a key role in mediating fibroblast-like synoviocyte intercellular adhesion and synovial tissue organization. (See Figure 1) Mice that are genetically deficient in cadherin-11 have a hypoplastic synovial lining. When challenged with arthritogenic antibodies, cadherin-11–deficient mice developed less paw swelling than normal mice and the synovial tissue appeared to lack the usual dense organization on histological examination. In this experiment, fibroblasts in the local microenvironment appeared necessary for the full function of other cell types in the inflammatory process.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Research Reviews Tagged With: anti-tumor necrosis factor, Reading Rheum, Research, Rheumatoid Arthritis (RA), spondylarthropathy, Treatment, UveitisIssue: April 2007

You Might Also Like:
  • Reading Rheum
  • Reading Rheum
  • Reading RHEUM
  • Reading Rheum

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)